CLINICAL_TRIALS
trial_result
· 2026-02-17
Clinical Trial Update: SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years [Phase 3]
Summary
Phase 3 trial update for SkyVaricella (NBP608) in healthy children shows lower potencies. The study is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SK Bioscience Co., Ltd. | Conditions: Varicella (Chickenpox) | Phase 3 | Status: NOT_YET_RECRUITING